HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New PhytoCellTec Argan Extract “Vitalizes” Dermal Stem Cells

This article was originally published in The Rose Sheet

Executive Summary

Mibelle Biochemistry’s PhytoCellTec Argan, derived from Morocco’s endangered Argan tree, extends the firm’s portfolio of anti-aging stem-cell technologies derived from plants and fruits.

You may also be interested in...



Mibelle Looks To Maintain Momentum In Plant Stem Cells

Mibelle’s R&D team has been working to expand the company’s actives portfolio and capitalize on the popularity of plant stem cells that can fend off the signs of aging.

Food-Focused Beauty On The Rise; Ingredients Perceived As Natural-est

Food-based ingredients are growing in popularity, given perceived purity of products and availability of agricultural substances, suggests Organic Monitor's Judi Beerling, who notes more and more edible products are hitting market. She discussed food ingredients during a session of the recent Sustainable Cosmetics Summit in Paris.

Global Biodiversity Pact’s Potential Impact On Personal Care Still Unclear

Six months after the adoption of the Nagoya Protocol – an international treaty conceived to help ensure fairness in the way genetic resources are mined for research and development purposes – the extent to which the personal-care industry will be impacted is still not entirely clear.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel